Roles of Signal Transducer Pathways in Investigation of Biopsies from Patients with Bladder Tumors

Document Type : Research Articles


1 Department of Internal Medicine, Division of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

2 Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

3 Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

4 Department of Urology, Bezmialem Vakif University Faculty of Medicine, İstanbul, Turkey


Background:The process of development of bladder cancer features alteration of normal biological conditions caused by changes in molecular pathways. Removing control over regulation of these pathways could lead to changes in signal transduction and abnormal regulation of genes. During tumor formation and progression, genes regulate critical cellular processes, involved in cell cycling, growth and death. Here we evaluated the expression and prognostic importance of FGFR1, HRAS, CCND1, CCND3, STAT3 and FAS genes. Methods: Tumor tissues of 44 patients diagnosed with bladder cancer were investigated for changes in expression levels of FGFR1, HRAS, CCND1, CCND3, FAS and STAT3 genes by the RT-PCR method. Signal transduction pathways and expression of individual genes related to these pathways were analyzed using the "One Sample Test". Results: There were statistically significant changes in the expression levels of HRAS, CCND1, CCND3 and STAT3, but not FGFR1 and FAS genes. Examination of associations with age, gender, smoking, chemotherapy, tumor grade and tumor growth pattern using the "Independent Samples Test", showed importance relations between the CCND1 gene and cigarette smoking and sex. Conclusion: Over-expression of HRAS, CCND1, CCND3 and STAT3 genes may play roles in bladder cancer development and progression, while cigarette smoking is significantly associated with CCND1 gene expression and consequently concluded to be contributing to the development of bladder cancer.


Volume 18, Issue 1
January 2017
Pages 201-205
  • Receive Date: 07 December 2016
  • Revise Date: 15 January 2017
  • Accept Date: 08 February 2017
  • First Publish Date: 08 February 2017